Rasagiline and FDA
Links shared publicly online about this topic
Watson seeks FDA approval to market rasagiline mesylate tablets
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.” View full resource at news-medical.net
Most Recently Shared on October 6, 2010 at 6:49 am By:
Watson seeks FDA approval to market rasagiline mesylate tablets: Watson Pharmaceuticals, Inc. today confirmed that... http://bit.ly/c4479C
MT @ParkinsonDotOrg Joint statement from 6 #Parkinsons orgs about FDA hearing 2 change labeling on Azilect (rasagiline) http://t.co/ZXwNntnF
parkinson.org — “MT @ParkinsonDotOrg Joint statement from 6 #Parkinsons orgs about FDA hearing 2 change labeling on Azilect (rasagiline) http://t.co/ZXwNntnF” View full resource at parkinson.org
Most Recently Shared on October 17, 2011 at 8:15 pm By:
Parkinson's SanDiego Health Organization
MT @ParkinsonDotOrg Joint statement from 6 #Parkinsons orgs about FDA hearing 2 change labeling on Azilect (rasagiline) http://t.co/ZXwNntnF
FDA Approves Newly Revised Prescribing Information for Azilect Reducing Medication and Food Restrictions
drugs.com — “Azilect (rasagiline) is used for Parkinson’s Disease. Information from Drugs.com includes Azilect side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 15, 2009 at 10:13 pm By:
FDA Approves New Prescribing Information for Azilect Reducing Medication and Food Restrictions - http://bit.ly/8BJT52
FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions
medicalnewstoday.com — “Teva Pharmaceutical Industries, Ltd. (NASDAQ: TEVA) announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) r” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2009 at 8:11 pm By:
MNT Parkinson's News Health News
FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions http://mnt.to/3vwn
Medical News: Parkinson's Drug Doesn't Slow Disease Progress, FDA Staff Says - in Neurology, Parkinson's Disease from MedPage Today
medpagetoday.com — “WASHINGTON -- Azilect (rasagiline), which is already approved to treat symptoms of Parkinson's disease, does not appear effective at slowing progression of the neurodegenerative disease, according to” View full resource at medpagetoday.com
Most Recently Shared on October 14, 2011 at 9:59 pm By:
Parkinson's Drug Doesn't Slow Disease Progress, FDA Staff Says - in Neurology, - http://t.co/kGJft1rq from @medpagetoday
Medical News: FDA Cuts Food and Drug Restrictions for Parkinson's Medication - in Product Alert, Devices and Vaccines from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA reduced food and medication restrictions for the Parkinson's drug rasagiline (Azilect) on the tablet's prescribing information.” View full resource at medpagetoday.com
Most Recently Shared on December 15, 2009 at 3:38 pm By:
FDA Cuts Food and Drug Restrictions for Parkinson's Medication WASHINGTON (MedPage Today) -- The FDA reduced food and.. http://bit.ly/4uLuYs
Azilect Prescribing Information updated to reflect reduced medication and food restrictions - MPR
empr.com — “Teva Pharmaceuticals announced that the FDA has approved revised Prescribing Information for Azilect (rasagiline tablets) reducing medication and food restrictions.” View full resource at empr.com
Most Recently Shared on December 15, 2009 at 3:55 pm By:
MPR News: Azilect Prescribing Information updated to reflect reduced medication and food restrictions: Teva Pharmac... http://bit.ly/7ZRfh4
Teva Pharmaceutical Industries receives approval for newly revised prescribing information for AZILECT
news-medical.net — “Teva Pharmaceutical Industries, Ltd. today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) reducing medication and food restrictions.” View full resource at news-medical.net
Most Recently Shared on December 15, 2009 at 9:57 pm By:
Parkinson's Disease: Teva Pharmaceutical Industries receives approval for newly revised prescribing information for... http://bit.ly/4A228i
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Medical News from Around the World
-
Parkinson's SanDiego
The Parkinson's Association of San Diego supports people with PD and their families with information, educational programs and family services.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
